Skip to main content
. 2020 Sep 5;8(9):331. doi: 10.3390/biomedicines8090331

Table 2.

Effects of psilocybin on depression and anxiety.

Outcome Analyzed Number of Effect Sizes WMD Observed (95% CI) p-Value I2 (%) Model USED WMD Adjusted
(95% CI)
BDI 11 −4.589 0.002 * 0 Fixed −4.589
(−4.207 to −0.971) (−4.207 to −0.971)
STAI-Trait 11 −5.906 <0.001 * 0 Fixed −6.389
(−7.852 to −3.960) (−8.151 to −4.626)
STAI-State 9 −6.032 <0.001 * 0 Fixed −6.032
(−8.900 to −3.164) (−8.900 to −3.164)

WMD—weighted mean differences; CI—confidence interval; * Indicates a significant result.